Clinical trials
Phase 2/3 Recurrence trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2006 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 2 |
| Completed | 2 |
| Recruiting | 2 |
| Terminated | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alexion Pharmaceuticals, Inc. | 1 |
| BioNTech SE | 1 |
| Clovis Oncology, Inc. | 1 |
| Geron Corporation | 1 |
| Global Coalition for Adaptive Research | 1 |
| Heidelberg University | 1 |
| Kiniksa Pharmaceuticals International, plc | 1 |
| University Hospital, Bonn | 1 |
| WiSP Wissenschaftlicher Service Pharma GmbH | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 9 |
| Neoplasm Metastasis | 2 |
| Brain Neoplasms | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Colitis, Ulcerative | 1 |
| Demyelinating Diseases | 1 |
| Ependymoma | 1 |
| Glioblastoma | 1 |
| Head and Neck Neoplasms | 1 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.